Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
It is indicated for the treatment of thrombocytopenia in adult patients with chr···【more】
Release date：2026-01-05Recommended：20
It is indicated for the treatment of adult patients with pulmonary arterial hype···【more】
Release date：2026-01-05Recommended：20
It is indicated for the treatment of adult patients with symptomatic obstructive···【more】
Release date：2026-01-05Recommended：13
It is indicated for the treatment of early-stage and advanced-stage HER2-positiv···【more】
Release date：2026-01-05Recommended：5
It is indicated for the treatment of idiopathic pulmonary fibrosis (IPF), chroni···【more】
Release date：2026-01-05Recommended：22
It is indicated for the treatment of relapsed or refractory acute leukemia (with···【more】
Release date：2026-01-05Recommended：12
It is indicated for the treatment of cholestatic pruritus in patients aged 3 mon···【more】
Release date：2026-01-05Recommended：6
It is indicated for the treatment of adult patients with intermediate- or high-r···【more】
Release date：2026-01-05Recommended：5
It is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).【more】
Release date：2026-01-05Recommended：12
On July 22, 2021, Merck & Co., Inc. and Eisai Co., Ltd. jointly announced th···【more】
Release date：2026-01-05Recommended：44
Merck & Co., Inc. and Eisai Co., Ltd. jointly announced today that the U.S. ···【more】
Release date：2026-01-05Recommended：41
Ivosidenib is mainly metabolized by the CYP3A4 enzyme. Co-administration with dr···【more】
Release date：2026-01-04Recommended：89
